Policy relevant results from an expert elicitation on the human health risks of decabromodiphenyl ether (decaBDE) and hexabromocyclododecane (HBCD).

Ravnum, S.; Zimmer, K.E.; Keune, H.; Gutleb, A.C.; Murk, A.J.; Koppe, J.G.; Magnanti, B.; Lyche, J.L.; Eriksen, G.S.; Ropstad, E.; Skaare, J.U.; Kobernus, M.; Yang, A.; Bartonova, A.; von Krauss, M.K.